Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Dopamine d2 Receptor Antikörper (Extracellular)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch Dopamine d2 Receptor in WB, IHC, FACS und LCI. Er zeigt eine Reaktivität gegenüber Ratte.
Produktnummer ABIN7043107

Kurzübersicht für Dopamine d2 Receptor Antikörper (Extracellular) (ABIN7043107)

Target

Alle Dopamine d2 Receptor (DRD2) Antikörper anzeigen
Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))

Reaktivität

  • 68
  • 53
  • 49
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Ratte

Wirt

  • 77
  • 9
Kaninchen

Klonalität

  • 76
  • 9
Polyklonal

Konjugat

  • 40
  • 6
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Dopamine d2 Receptor Antikörper ist unkonjugiert

Applikation

  • 74
  • 30
  • 26
  • 26
  • 23
  • 17
  • 14
  • 12
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Live Cell Imaging (LCI)
  • Bindungsspezifität

    • 15
    • 15
    • 9
    • 5
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 11-26, Extracellular

    Verwendungszweck

    A Rabbit Polyclonal Antibody to D2 Dopamine Receptor

    Spezifität

    Extracellular, N-terminus

    Kreuzreaktivität

    Human, Maus, Ratte

    Homologie

    Mouse - identical, human - 15,16 amino acid residues identical

    Produktmerkmale

    Anti-D2 Dopamine Receptor (extracellular) Antibody (ABIN7043107, ABIN7044229 and ABIN7044230) is a highly specific antibody directed against an epitope of the rat protein. The antibody can be used in western blot and immunohistochemistry applications. It has been designed to recognize DRD2 from rat, human, and mouse samples.

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    Immunogen: Synthetic peptide

    Immunogen Sequence: (C)DDLERQNWSRPFNGSE, corresponding to amino acid residues 11-26 of rat DRD2 

    Isotyp

    IgG
  • Applikationshinweise

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: N/A

    Application Dilutions Western blot wb: 1:200

    Kommentare

    Cited Application: IP|IFC

    Negative Control: (ABIN7235239)

    Blocking Peptide: (ABIN7235239)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Recosntitute with double distilled water (DDW) to a concentration of 1.0 mg/mL.

    Konzentration

    1 mg/mL

    Buffer

    PBS pH 7.4

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Target

    Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))

    Andere Bezeichnung

    DRD2

    Hintergrund

    DRD2, D(2) dopamine receptor,The D2 dopamine receptor (DRD2) is one of five receptors that mediate the effects of the catecholamine neurotransmitter dopamine. Dopamine regulates a variety of functions including locomotor activity, emotion, positive reinforcement, food intake, and endocrine regulation. The dopaminergic system has been extensively studied in the last thirty years mainly because its dysregulation has been linked to several neurological and neuropsychiatric diseases including Parkinson's disease and schizophrenia.1All five dopamine receptors belong to the 7-transmembrane domain, G protein-coupled receptor (GPCR) superfamily.Historically, the five receptors have been divided into two subfamilies based on pharmacological and structural considerations: the D1-like subfamily (that includes the D1 and D5 subtypes) and the D2-like subfamily (that includes the D2-, D3- and D4 subtypes).1The D1-like receptors are coupled to Gs-type G proteins and enhance adenylate cyclase activity while the D2-like receptors are coupled to Gi-type G proteins and inhibit adenylate cyclase activity.1D2 receptor expression in the brain is largely confined to the striatum, prefrontal cortex and hypothalamus.1Dysregulation of D2 receptor function has been implicated in several disorders including schizophrenia, bipolar disorder, Parkinson's disease, and restless legs syndrome. Consistent with this, treatments that either block or activate the D2 receptor have been developed to treat these diseases.2

    Alternative names: D2 Dopamine Receptor, DRD2, D(2) dopamine receptor

    Gen-ID

    24318

    NCBI Accession

    NM_000795

    UniProt

    P61169

    Pathways

    Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
Sie sind hier:
Chat with us!